<p>(RTTNews) - Co-Diagnostics, Inc. (CODX) 是一家分子诊断公司，宣布已与某些机构投资者签署证券购买协议，计划通过私募发行出售总计 165 万股普通股或预先融资的认股权证，以及可购买总计 329.5 万股普通股的认股权证。</p>
<p>此次发行预计将产生约 300 万美元的毛收益，计划于 2026 年 5 月 21 日左右完成。</p>
<p>每股普通股或预先融资的认股权证及随附认股权证的综合发行价格为 1.821 美元。</p>
<p>认股权证的行使价格为每股 1.571 美元，发行后可立即行使，且自发行之日起五年内有效。</p>
<p>Maxim Group LLC 作为此次发行的唯一配售代理。</p>
<p>在过去一年中，CODX 的交易区间为 1.26 美元至 46.50 美元。该股票在周二的交易中收于 1.97 美元，上涨 43.80%。</p>
<p>在隔夜市场中，CODX 下跌 0.51%，报 1.96 美元。</p>
<p>欲获取更多此类新闻，请访问 rttnews.com。</p>
<p>本文所表达的观点和意见仅代表作者个人观点，并不一定反映纳斯达克公司的观点。</p>

CODX

纳斯达克生物科技指数 ETF - iShares Nasdaq

生物科技 ETF - VanEck Vectors

动态生物技术与基因组 ETF - Invesco

标普生物技术 3 倍做多 - Direxion

标普生物技术 ETF - SPDR

2 倍做多纳斯达克生物技术 ETF - ProShares

医药突破 ETF - ALPS

纽交所高增长板生物技术指数 ETF - First Trust

<p>Co-Diagnostics, Inc. (CODX) 宣布进行私人配售，出售 165 万股股票和认股权证，总金额约为 300 万美元。此次发行预计将在 2026 年 5 月 21 日左右完成，股票的综合价格为每股 1.821 美元。认股权证的行使价格为 1.571 美元，五年后到期。CODX 股票收盘价为 1.97 美元，上涨 43.80%，但在隔夜市场下跌 0.51%</p>

<p>(RTTNews) - Co-Diagnostics, Inc. (CODX), a molecular diagnostics company, announced that it has entered into a securities purchase agreement with certain institutional investors to sell an aggregate of 1.65 million shares of common stock or pre-funded warrants, together with warrants to purchase up to an aggregate of 3.295 million shares of common stock, in a private placement.</p>
<div class="lb-trans"><p>(RTTNews) - Co-Diagnostics, Inc. (CODX) 是一家分子诊断公司，宣布已与某些机构投资者签署证券购买协议，计划通过私募发行出售总计 165 万股普通股或预先融资的认股权证，以及可购买总计 329.5 万股普通股的认股权证。</p>
</div><p>The offering is expected to generate gross proceeds of approximately $3 million and is scheduled to close on or about May 21, 2026.</p>
<div class="lb-trans"><p>此次发行预计将产生约 300 万美元的毛收益，计划于 2026 年 5 月 21 日左右完成。</p>
</div><p>The combined offering price for each share of common stock or pre-funded warrant, and the accompanying warrants to be issued, is $1.821.</p>
<div class="lb-trans"><p>每股普通股或预先融资的认股权证及随附认股权证的综合发行价格为 1.821 美元。</p>
</div><p>The warrants will have an exercise price of $1.571 per share and will be exercisable immediately upon issuance, and will expire five years from the date of issuance.</p>
<div class="lb-trans"><p>认股权证的行使价格为每股 1.571 美元，发行后可立即行使，且自发行之日起五年内有效。</p>
</div><p>Maxim Group LLC is acting as the sole placement agent in connection with the offering.</p>
<div class="lb-trans"><p>Maxim Group LLC 作为此次发行的唯一配售代理。</p>
</div><p>CODX has traded between $1.26 and $46.50 over the last year. The stock closed Tuesday's trade at $1.97, up 43.80%.</p>
<div class="lb-trans"><p>在过去一年中，CODX 的交易区间为 1.26 美元至 46.50 美元。该股票在周二的交易中收于 1.97 美元，上涨 43.80%。</p>
</div><p>In the overnight market, CODX is down 0.51% at $1.96.</p>
<div class="lb-trans"><p>在隔夜市场中，CODX 下跌 0.51%，报 1.96 美元。</p>
</div><p>For more such news For More Such Biotech Stock News, visit rttnews.com.</p>
<div class="lb-trans"><p>欲获取更多此类新闻，请访问 rttnews.com。</p>
</div><p>The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.</p>
<div class="lb-trans"><p>本文所表达的观点和意见仅代表作者个人观点，并不一定反映纳斯达克公司的观点。</p>
</div>

Co-Diagnostics Unveils $3 Mln Private Placement Of Shares And Warrants

nasdaq

Co-Diagnostics

纳斯达克 OMX 交易所

Co-Diagnostics 宣布进行 300 万美元的股份和认股权证私募发行